The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Clinical trial NCT05763953 · RECRUITING

Trial details

NCT number: NCT05763953
Sponsor: Milestone Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Paroxysmal Supraventricular Tachycardia

Start date: 2023-12-11
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.